We have launched a call for proposals for our #ResearchGrantProgram 📢

The JPMA provides grants aimed at contributing to solving challenges in healthcare, health, and the pharmaceutical industry through interdisciplinary research and support for early-career researchers.
🗓️ The application deadline is Monday, November 16.

Click here for detailed program information 👇
https://www.jpma.or.jp/information/industrial_policy/researchsupport/index.html

#Japan Pharmaceutical Manufacturers Association (JPMA) #Newsletter The July 2026 issue (No. 230) has been published! ✨

✅Featured Interview: “Business Strategy Division”
✅From JPMA: “Interview with the New Chairperson”
✅My Committee: “Regulatory Affairs Committee”
✅The Pharmaceutical Industry Through the Lens of Facts
✅Key Term to Watch: “Public-Private Investment Roadmap”
✅Topics

Be sure to check it out 👇
https://www.jpma.or.jp/news_room/newsletter/230/index.html

The #Quality & Technology Committee will once again host the “GMP Case Study Seminar” on Friday, September 25, 2026!

Under the theme “Integrating On-Site Capabilities, Equipment Reliability, and Digital Technology to Enhance the Effectiveness of Quality Assurance,” the event will feature a special lecture by the PMDA and three presentations from companies and industry representatives. We look forward to your participation!

Register here 👇
https://www.jpma.or.jp/news_room/event/information/GMP2026.html

🆕#JPMA News Release
Following the Cabinet’s approval of the “#Basic Policy 2026,” the #JPMA has Chairman #Miyashira .

We welcome the fact that drug discovery and advanced medical care have been positioned as key sectors supporting Japan’s growth, and that a direction has been set to appropriately evaluate the value of innovative new drugs.

Click here for the statement: https://www.jpma.or.jp/news_room/release/2026/260721.html

Yesterday, Vice Chairman Okuda of the #JPMA took the stage at the organizer panel session titled “Global Collaboration” during Day 1 of the #NIKKEI Drug Discovery Ecosystem Summit!

He emphasized the importance of building a drug discovery ecosystem where drug discovery seeds and intellectual property (IP) are generated based on strong basic research capabilities, and where capital and talent accumulate and circulate. 🌱

Click here for the day’s program 👇
https://events.nikkei.co.jp/81973/

#International Affairs Committee: Europe and U.S. Subcommittee and Field Trip Subcommittee @Tokushima

As part of the annual field trip subcommittee—which includes visits to facilities owned by member companies—we visited the Otsuka Pharmaceutical plant in Naruto City, Tokushima Prefecture this year.

Participants learned about the history, technology, and evolution of intravenous solutions while touring the birthplace of the Otsuka Group. They also engaged in lively discussions with one another.

#JPMA

July 6 is Vaccine Day. On this day in 1885, Pasteur administered the first human vaccination against rabies. Vaccines can prevent disease. From children to adults, accurate knowledge leads to peace of mind. You can learn about the history of Pasteur’s pioneering work at the Pharmaceutical Research Institute 👇

https://www.jpma.or.jp/junior/kusurilabo/history/person/pasteur.html

#VaccinePracticeCommittee #VaccineDay

# OPIR Views and Actions No. 78 (July 2026) has been published 📰

✅ Status of Drug Development for Unmet Medical Needs

In addition, we feature surveys, analyses, and research on the pharmaceutical industry, as well as updates on the Policy Research Institute’s activities 📊

⬇ Click here for details
https://www.jpma.or.jp/opir/news/index.html

#PolicyResearchInstitute #PharmaceuticalMarket #AI

In addition to Prime Minister Takaichi, Chairman Miyashira, President Kinoshita, and Executive Director Takahashi from the #JPMA also participated in meetings with Finance Minister Katayama, Health, Labor, and Welfare Minister Ueno, and LDP Policy Research Council Chairman Kobayashi!

The Biopharmaceutical CEOs Roundtable ( #BCR ) was held in Tokyo!
The #JPMA, together with leaders of global biopharmaceutical companies, participated in an exchange of views with #PrimeMinister Sanae Takaichi 🤝
Lively discussions took place regarding the promotion of innovation through drug discovery and advanced medical care, as well as strengthening Japan’s competitiveness in the life sciences.
(Photo courtesy of the Prime Minister’s Office 📸)

🆕#JPMA News Release

A delegation of more than 20 leaders from major biopharmaceutical companies in the U.S., Japan, and Europe met with Prime Minister Sanae Takaichi this week to discuss the initiatives necessary for Japan to maintain and strengthen its leadership in the life sciences sector.

Click here for details 👇
https://www.jpma.or.jp/news_room/release/2026/260528.html

Co-hosted a side event with the Permanent Mission of Japan to the International Organizations in Geneva at the 79th World Health Assembly (WHA79).

Approximately 45 participants, including ministers from Ghana, Fiji, Jamaica, and Vietnam, as well as representatives from international organizations and NGOs, attended the event to share insights on Japan’s “Kenshin” (health checkups) and examples from their respective countries. A lively discussion took place on strengthening sustainable health systems through prevention and early detection.

#International Affairs Committee

🎉Today, May 1
The JPMA, which has marked many milestones since its founding in 1968, celebrated its anniversary!
We would like to express our heartfelt gratitude to the many people who have supported us throughout our journey.

And with this day marking a new milestone—
We will continue to make steady preparations for our full-scale launch as a general incorporated association, scheduled for October ✨

#Miyashira’sMusings💬
The #JapanGrowthStrategyCouncil, which has held discussions for about four months.
Following the Drug Discovery and Advanced Medical Care Working Group, I also participated in the final session of the Synthetic Biology and Biotechnology Working Group!

I would like to express my heartfelt gratitude to all the members and to the officials from the relevant ministries and agencies who worked so hard to bring this together.

Drawing strength from the roadmap we’ve mapped out together, all that’s left is to move forward!
#JPMA

#Miyashira’s Musings💬
I participated in the final meeting of the #Japan Growth Strategy Council’s “Drug Discovery and Advanced Medical Care Working Group,” following nearly four months of discussions!

The pharmaceutical industry is a vital strategic sector that supports life, health, economic growth, and national security.

Bringing innovative Japanese pharmaceuticals to the world —
Let’s move forward as one—government and industry united!
#JPMA

#Miyashira’s Musings💬

Speaking at #CPHI2026!
The true measure of success in healthcare digital transformation is “what benefits have reached each and every citizen.”
Quality of care, work styles, management, and patient outcomes.
Quantitatively demonstrating value accelerates the next phase of implementation.
I am grateful for the opportunity to discuss the potential of the future healthcare ecosystem.

The “15th Asia Pharmaceutical Association Conference ( #APAC )” was held on April 21.

This year, we once again welcomed not only representatives from pharmaceutical associations but also regulatory authorities and academics from various Asian countries and regions, including Japan. With approximately 700 participants, we held meaningful discussions. ✨

Click here for this year’s agreed items 👇
https://www.jpma.or.jp/news_room/release/2026/260422_02.html

#JPMA

#JPMA #International Affairs Committee regularly exchanges information with overseas pharmaceutical associations, and this time held an online meeting with #EFPIA.

During the meeting, both JPMA and EFPIA shared updates on policy and regulatory trends affecting the pharmaceutical industry and exchanged views on common challenges such as most-favored-nation treatment and tariffs.

The North America Group of the Europe and America Subcommittee under the #JPMA #International Affairs Committee hosted a study session featuring Mr. Lu (Greenberg Traurig), a lawyer practicing in the United States, as a guest speaker.

He spoke about policy and regulatory trends surrounding the U.S. pharmaceutical industry, and participants exchanged views.

🆕News Release

The Council for the Proper Use of Medicines, the Japan Pharmacists Association, and the JPMA collaborated to produce “Don’t Take Information at Face Value!”—an educational resource for the general public that summarizes tips for evaluating medical and health information—which was published on each organization’s website on April 9.

Click here for details 👇
https://www.jpma.or.jp/news_room/release/2026/260409.html

“Drug Discovery Karuta,” created by middle and high school girls, is now available! ✨

Download here 👇
https://www.jpma.or.jp/information/industrial_policy/report/260402.html

They expressed the realities of drug discovery—including AI, iPS cells, drug-resistant bacteria, and drug loss—in their own words!
#GirlsMeetSTEM #STEM #ScienceandTechnologyMuseum #AlchemyNote

On April 3, we held an exchange meeting between the#JPMA #Quality & Technology Committee’s Quality Culture Project and the Toyama Pharmaceutical Association. This marks the third such meeting, following those held in 2025.

On the day of the event, lively discussions took place regarding quality culture. The content of this exchange will be shared with the JPMA GMP Case Study Group in the future and utilized to further our quality assurance efforts!

On March 28, #JPMA Chairman Miyashira took the stage at the Pharmaceutical Society of Japan’s Diversity Promotion Symposium! He spoke about talent development initiatives in the pharmaceutical industry and the importance of diversity in driving innovation!

#JPMA held a career awareness seminar for middle and high school students at the Japanese Pharmaceutical Society’s Annual Meeting last weekend ✨

How are medicines created and delivered to patients? 💊 Through this story, we introduced the appeal and fulfillment of careers in pharmacy and drug discovery!

We hope this serves as an opportunity for the young people who will lead the next generation of pharmacy and drug discovery to envision their own futures🌱

#JPMA also sponsored the “63rd Senden Kaigi Awards: Junior High and High School Division.”
From among the many entries, more than 100 JPMA members participated in the judging process and selected six winning taglines🏅

Congratulations to all the winners!🎉
The selected entries will be used in the JPMA’s future public relations activities!

Click here for details on the judging process and interviews with the winners 👇
https://www.jpma.or.jp/information/public_affairs/pr/2025/index.html

🌐 The JPMA website homepage has been redesigned

Based on the three pillars of JPMA’s Vision for 2035 (Innovation, Access, and Trust), we’ve reorganized the site to better organize and visualize JPMA’s activities. 👇

https://www.jpma.or.jp/

Following the recent introduction of “automatic translation (English),” we will continue to strive to strengthen our ability to communicate both domestically and internationally ✨